Decitabine

NDC 72205-031 · Novadoz Pharmaceuticals LLC

Generic nameDecitabine

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DECITABINE

Strength50 mg/10mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

72205-031-01 — 1 VIAL, SINGLE-USE in 1 CARTON (72205-031-01) / 20 mL in 1 VIAL, SINGLE-USE

J0894 — Injection, decitabine, 1 mg Medicare Part B payment limit (ASP + 6%): $1.06

FDA lists these products with the same active ingredient.

0143-9385 — decitabine, 16729-224 — decitabine, 25021-219 — Decitabine, 31722-304 — Decitabine, 43598-427 — Decitabine, 55111-556 — Decitabine, 55150-376 — Decitabine, 64842-0727 — CEDAZURIDINE and DECITABINE, 67184-0535 — decitabine, 67457-316 — decitabine, 68001-573 — decitabine, 68001-618 — Decitabine, 68001-642 — Decitabine, 68083-528 — decitabine, 70121-1644 — decitabine, 71288-119 — Decitabine, 72162-2634 — Decitabine, 72205-036 — Decitabine, 72603-107 — Decitabine, 75834-190 — decitabine

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.